Leo Laboratories Limited

Longwick Road, Princes Risborough, Bucks., HP27 9RR
Telephone: +44 (0)1844 347 333
Fax: +44 (0)1844 276 385
Medical Information e-mail: medical-info.uk@leo-pharma.com

Patient Information Leaflet last updated on the eMC: 28/10/2011
PIL Dovobet Ointment

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 23/02/2011 and displayed until 28/10/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 03/09/2008 and displayed until 23/02/2011
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 22/01/2008 and displayed until 03/09/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 07/06/2007 and displayed until 22/01/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/11/2006 and displayed until 07/06/2007
Reasons for adding or updating:
  • Introduction of new pack
  • Change to side-effects
  • Change to date of revision
Updated on 10/05/2006 and displayed until 01/11/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 23/02/2005 and displayed until 10/05/2006
Reasons for adding or updating:
  • Change to storage instructions
  • Change to date of revision
Updated on 09/12/2003 and displayed until 23/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 10/11/2003 and displayed until 09/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 28/10/2002 and displayed until 10/11/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 01/05/2002 and displayed until 28/10/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   betamethasone dipropionate
   calcipotriol monohydrate